Partnering & Outsourcing Editorial

  1. Remote Candidate Fraud In Clinical Research: A Cautionary Tale For Interviewers 5/23/2023

    You interviewed a remote candidate for a technical role who nailed it. The interview panel unanimously agreed to move forward, and the candidate skated through the new hire screening. You set them up on a project that fits their skillset perfectly, and you were excited for their first day. But when the candidate started, things seemed… off.

  2. India's CROs & CDMOs Come Of Age In The Global Marketplace 5/4/2023

    Most of the top 10 pharmaceutical companies and many large biotech companies today get a portion of their preclinical/clinical research, drug development, and/or manufacturing done in India. While a low price is the initial attraction, there are additional factors that can be more meaningful.

  3. Key Considerations For Working With CROs 4/25/2023

    Learn the key considerations for selecting a clinical research organization (CRO) outsourcing partner for your clinical trial as well as how to mitigate the four common challenges while working with CROs.

  4. Why Every Pharma Needs A Service Management Group (SMG) For Successful Outsourcing 4/24/2023

    A comprehensive end-to-end sourcing and outsourcing approach can allow life science companies to realize their clinical transformation objectives. One of the critical areas not getting enough attention is the design and development of an internal, dedicated Service Management Group (SMG) that is adequately staffed, trained, and empowered to manage the multiple suppliers and the strategic objectives of the outsourcing programs.

  5. Need To Clean Up Your Clinical Trials Budgeting And Forecasting Process? Try MOP-FACE 4/17/2023

    Like the CTM who drinks CDER at the SPA without getting anyone SAD or MAD, our industry enjoys a good acronym. As such, here is the acronym to remember that will lead you to budgeting enlightenment: MOP-FACE.

  6. New EU Directive Marks Cybersecurity Regulatory Paradigm Shift For Bio/Pharma & Medical Devices 2/15/2023

    The EU's new Directive 2022/2555 on the Security of Network and Information Systems (“NIS2”) mandates cybersecurity risk management measures and reporting requirements for all segments of our industry, including labs; CROs and CDMOs; and manufacturers of APIs, bio/pharmaceuticals, and medical devices.

  7. The Secret(s) To Solving The Clinical Trials Staffing Crisis 2/10/2023

    In September 2022, there were 6.6 million clinical research jobs posted in the U.S. but only 5.7 million available hires. What accounts for the hiring gap, and how can it be narrowed? Kathi Enderes, SVP, research, and global industry analyst, at The Josh Bersin Company explains why looking outside the field is one way to address worker shortages.

  8. 4 Essential Drivers In Clinical Development For Emerging Biotechs 12/21/2022

    Enrollment, enrollment, enrollment has been the sponsor’s classic mantra for achieving success in a clinical trial. Rather, we should replace this notion with four equally essential building blocks: 1) the selection of the right CRO, 2) the identification of study sites, 3) the engagement of sites, and 4) the enrollment of patients.

  9. The Future Of TransCelerate: Clinical Trial Modernization 12/19/2022

    In January 2023, Janice Chang will take over as the head of industry consortia non-profit organization TransCelerate. Chang has been involved with TransCelerate since it was just a concept, and notes the time spent in the group since its launch has been an amazing journey.

  10. Boehringer Ingelheim Implements One Medicine Technology Platform 12/8/2022

    For years, Boehringer Ingelheim operated with a system comprised of best-of-breed solutions from different vendor companies. After carefully evaluating the technology environment, the company decided to move from best-of-breed solutions to an end-to-end product development platform.